Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Sant Cugat del Vallès
Clinical trial register · Spain

Clinical Trials in Sant Cugat del Vallès, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universitat Internacional de Catalunya10 Hoffmann-La Roche7 Fundacion Dexeus4 Aesculap AG3 AstraZeneca2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Sant Cugat del Vallès

52 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Fundacion Dexeus
Phase 4
154
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-10-15
Recruiting
Universitat Internacional de Catalunya
Not applicable
23
Sant Cugat del Vallès
2026-09-01
Not yet open
Fundacion Dexeus
Phase 4
240
Sabadell, Sant Cugat del Vallès, Barcelona, Tarragona
2026-09
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Barcelona, Córdoba, Lleida, Madrid, Ourense, Sant Cugat del Vallès
2026-04-16
Recruiting
AI-TOP Study Artificial Intelligence for Trigger Optimization.
NCT07515118Infertility, Ovarian Stimulation, Artificial Intelligence
Fundacion Dexeus
Not applicable
644
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-04-08
Not yet open
Universitat Internacional de Catalunya
Not applicable
30
Sant Cugat del Vallès
2026-03
Active, closed
Hoffmann-La Roche
Phase 1
6
Sant Cugat del Vallès, Barcelona, Córdoba
2026-01-27
Recruiting
Fundacion Dexeus
Phase 4
62
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-01-19
Recruiting
Pharmanutra S.p.a.
Phase 4
146
Barcelona, Málaga, Sant Cugat del Vallès, Zaragoza
2025-12-11
Not yet open
Universitat Internacional de Catalunya
Not applicable
54
Sant Cugat del Vallès
2025-12
Recruiting
Hoffmann-La Roche
Phase 3
900
Elche, Sant Cugat del Vallès, Donostia / San Sebastian, A Coruña, Alcorcón, Pozuelo de Alarcón, Barcelona, Madrid
2025-11-24
Recruiting
Alnylam Pharmaceuticals
Phase 1
50
Barcelona, Madrid, Sant Cugat del Vallès
2025-10-15
Recruiting
Debriefing Styles and Clinical Judgment in Nursing Students
NCT07262424Simulation Based Learning, Nursing Education, Debriefing Method
Universitat Internacional de Catalunya
Not applicable
110
Sant Cugat del Vallès
2025-10-10
Not yet open
Escoles Universitaries Gimbernat
Observational
54
Sant Cugat del Vallès
2025-10-01
Not yet open
Escoles Universitaries Gimbernat
Not applicable
40
Sant Cugat del Vallès
2025-10-01
Not yet open
Universitat Internacional de Catalunya
Not applicable
32
Sant Cugat del Vallès
2025-09-20
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Sant Cugat del Vallès, Terrassa, Donostia / San Sebastian, Lleida, Pozuelo de Alarcón, Barcelona, Córdoba, Madrid
2025-09-17
Recruiting
Bristol-Myers Squibb
Phase 3
586
Seville, Sant Cugat del Vallès, Barcelona, Lleida, Pamplona, Madrid
2025-07-14
Recruiting
OMIQ Research
Not applicable
80
Sant Cugat del Vallès
2025-06-27
Recruiting
Aesculap AG
Not applicable
68
Barcelona, Sant Cugat Del Vallés
2025-01-24
Recruiting
Clinical Performance of Printed Hybrid Resin in Indirect Restorations
NCT07465978Endodontically Treated Teeth, Indirect Restoration
Universitat Internacional de Catalunya
Not applicable
60
Sant Cugat del Vallès
2024-12-13
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Vigo, Seville, Badalona, Sant Cugat del Vallès, Sant Joan Despí, San Cristóbal de La Laguna, Cáceres, Móstoles
2024-09-27
Active, closed
Cerevance
Phase 3
330
Seville, Sant Cugat del Vallès, Barakaldo, San Sebastián, Valencia, Barcelona, Madrid
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Barcelona, Burjassot, Córdoba, Madrid, Majadahonda, Pamplona, Sant Cugat del Vallès, Seville
2024-09-19
Active, closed
Noema Pharma AG
Phase 2
164
Barcelona, Burgos, Madrid, Oviedo, Sant Cugat del Vallès, Seville
2024-09-10
Active, closed
Annexon, Inc.
Phase 3
659
Valencia, Barcelona, Córdoba, Madrid, Majadahonda, Sant Cugat del Vallès, Santiago de Compostela, Seville
2024-07-30
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Barcelona, Getxo, Lleida, Madrid, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Terrassa
2024-07-22
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Alicante, Barcelona, Madrid, Salamanca, Sant Cugat del Vallès, Seville, Valencia
2024-05-24
Active, closed
Boehringer Ingelheim
Phase 2
190
Barcelon, Madrid, Sant Cugat Del Vallés, Valencia
2024-05-15
Active, closed
Universitat Internacional de Catalunya
Not applicable
168
Sant Cugat del Vallès
2024-05-14
Active, closed
Aesculap AG
Observational
229
Sant Cugat del Vallès
2024-05-09
Active, closed
Hoffmann-La Roche
Phase 2
256
Sant Cugat del Vallès, Donostia / San Sebastian, Pozuelo de Alarcón, Salamaca, Barcelona, Córdoba, Madrid, Seville
2024-05-02
Active, closed
Bristol-Myers Squibb
Phase 2
310
Barcelona, Sant Cugat del Vallès, Lleida
2024-03-20
Active, closed
Acumen Pharmaceuticals
Phase 2
542
Sant Cugat del Vallès, Cuarte de Huerva, Barcelona, Donostia / San Sebastian, Getxo, Madrid, Seville, Valencia
2024-02-29
Active, closed
DualityBio Inc.
Phase 3
541
Barcelona, Sant Cugat del Vallès, Santiago de Compostela, Madrid, Majadahonda, Pozuelo de Alarcón, Málaga, Pamplona
2024-01-18
Recruiting
NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
NCT05813236Gingivitis, Gingival Diseases, Periodontal Diseases
Aesculap AG
Not applicable
84
Sant Cugat del Vallès
2023-06-28
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Barcelona, Lleida, Sant Cugat del Vallès, Valencia
2022-10-10
Recruiting
AstraZeneca
Phase 1/2
695
A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Seville
2022-06-24
Recruiting
Universitat Internacional de Catalunya
Not applicable
40
Sant Cugat del Vallès
2022-05-01
Recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection
Hospital Universitari de Bellvitge
Not applicable
820
Badalona, Calella, Granollers, L'Hospitalet de Llobregat, Manresa, Mataró, Sant Cugat del Vallès, Terrassa
2021-06-11
Active, closed
Hoffmann-La Roche
Phase 2
586
Elche, Sant Cugat del Vallès, Donosti-San Sebastián, A Coruña, Alcorcón, Móstoles, Pozuelo de Alarcón, Pamplona
2021-05-05
Recruiting
Ramón Pons Calabuig
Observational
120
Sant Cugat del Vallès
2021-05-05
Recruiting
Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants.
NCT04766255Soft Tissue Atrophy, Mucogingival Deformity on Edentulous Ridge, Edentulous Alveolar Ridge
Universitat Internacional de Catalunya
Phase 4
60
Sant Cugat del Vallès
2021-05-01
Active, closed
Hoffmann-La Roche
Phase 1/2
241
Sant Cugat del Vallès, Donostia / San Sebastian, Barcelona, Madrid, Valencia
2021-03-15
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Sant Cugat del Vallès, Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2020-12-21
Recruiting
Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer
NCT04528979Endodontic Disease, Endodontically Treated Teeth
Juan Gonzalo Olivieri
Not applicable
220
Sant Cugat del Vallès
2019-09-20
Active, closed
Eisai Inc.
Phase 3
1,906
Sant Cugat del Vallès, Getxo, Donostia / San Sebastian, Barcelona, Córdoba, Madrid, Salamanca, Seville
2019-03-27
Recruiting
Outcome of Endodontic Retreatment in One or Two Visits
NCT04527705Endodontic Disease, Endodontically Treated Teeth, Root Canal Infection
Universitat Internacional de Catalunya
Not applicable
110
Sant Cugat del Vallès
2018-09-20
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Active, closed
Hoffmann-La Roche
Phase 2
316
Sant Cugat del Vallès, Donostia / San Sebastian, Alcorcón, Pamplona/iruña, Barcelona, Madrid, Seville
2017-06-27
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Barcelona, Cartagena, Jerez de la Frontera, Madrid, Málaga, San Sebastián de los Reyes, Sant Cugat del Vallès, Seville
2016-09-13
Active, closed
Fundacion IMIM
Observational
500
Hospitalet Llobregat,, L'Hospitalet de Llobregat, Sant Cugat del Vallès, San Sebastián, A Coruña, Barcelona, Madrid, Málaga
2003-04
Rows per page Showing 1–52 of 52
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/sant-cugat-del-vall-s

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 52 of those studies with a site in Sant Cugat del Vallès.

How many clinical trials are recruiting in Sant Cugat del Vallès?

23 of the 52 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 7 have not yet opened recruitment, 22 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sant Cugat del Vallès), 52 studies
PhaseStudiesRecruitingShare
Not applicable171232.7%
Phase 210019.2%
Phase 310419.2%
Phase 4539.6%
Observational417.7%
Phase 1/2315.8%
Phase 1213.8%
Phase 2/3111.9%

Most active sponsors

Lead sponsors with the most studies (Sant Cugat del Vallès)
Lead sponsorStudiesRecruiting
Universitat Internacional de Catalunya106
Hoffmann-La Roche71
Fundacion Dexeus42
Aesculap AG32
AstraZeneca21
Bristol-Myers Squibb21
Escoles Universitaries Gimbernat20
Acumen Pharmaceuticals10
Alnylam Pharmaceuticals11
Annexon, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.